Your institution may have access to this item. Find your institution then sign in to continue.
Title
Bazedoxifene: a guide to its use in postmenopausal osteoporosis.
Authors
Keating, Gillian M; Lyseng-Williamson, Katherine A; Duggan, Sean T; McKeage, Kate
Abstract
Oral bazedoxifene (Conbriza®) reduces the incidence of new vertebral fractures in patients with postmenopausal osteoporosis. It also appears to reduce the risk of nonvertebral fractures in high-risk patients. Bazedoxifene is generally well tolerated and does not appear to have detrimental effects on endometrial or breast tissue.